The biologics outsourcing industry has been witnessing optimal growth in recent years and is likely to continue even in upcoming years. The growth of biologics outsourcing ’s industry size can be attributed to rising investments in research & development activities, entry of new players, product innovation, technological breakthroughs, effective allocation of resources, and growing competition among business rivals to expand its regional as well as customer base. Supportive government policies and incentives, as well as favorable laws, are projected to determine the growth of the biologics outsourcing market in foreseeable future. An increase in the spending capacity of customers with the rise in disposable income will further contribute towards biologics outsourcing 's market proceeds.
This market research report is a comprehensive overview of the events taking place in the biologics outsourcing industry and impacting its growth. Our report divides the biologics outsourcing market into various segments or categories based on products, applications, region, etc. Additionally, our research analysts have listed the key players of the global biologics outsourcing market and compared them based on metrics such as market revenue, Y-O-Y sales, shipments volume, historical data, and successful implementation of business strategies such as strategic alliances, mergers & acquisitions, joint ventures, product development, and partnerships & collaborations.
Market Research Store (MRS) published a brand new report titled “Biologics Outsourcing Market research report which is segmented by Products (Antibody, Recombinant Protein, Vaccines, Others), by Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research), by Key Players/Companies GVK Biosciences Private Limited, Lonza, Abzena PLC, Shanghai Medicilon inc., GenScript, Horizon Discovery Group plc, Adimab LLC., Boehringer Ingelheim GmbH, Catalent Inc., Innovent Biologics Inc., Selexis SA, Syngene, Innovent Biologics Inc., GL Biochem Corporation Ltd.”. In 2020, the global biologics outsourcing market value was registered at XX (USD Million/Billion) and is predicted to reach XX (USD Million/Billion) at a CAGR of XX% by 2028.
Request Free Sample| Report Attributes | Report Details |
|---|---|
| Report Title | Biologics Outsourcing Market Research Report |
| By Products | Antibody, Recombinant Protein, Vaccines, Others |
| By Applications | Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research |
| By Key Players | GVK Biosciences Private Limited, Lonza, Abzena PLC, Shanghai Medicilon inc., GenScript, Horizon Discovery Group plc, Adimab LLC., Boehringer Ingelheim GmbH, Catalent Inc., Innovent Biologics Inc., Selexis SA, Syngene, Innovent Biologics Inc., GL Biochem Corporation Ltd. |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 116 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Based on these findings, the global biologics outsourcing industry study suggests strategies to existing market participants as to how they can improve & reinforce their market position. In addition to this, the study also recommends successful market penetrating strategies for new entrants. Furthermore, biologics outsourcing industry study report has included all major manufacturers and distributors operating in the biologics outsourcing market across all major regions.
Various analytical methods such as Porter’s Five Force Analysis, SWOT analysis, Market Share Analysis, Competitive Analysis, PESTEL Analysis, Market Attractiveness Analysis, and Value Chain Analysis have been used to analyze the market in the research report. These assessments help users of the report in examining and evaluating biologics outsourcing market on the basis of different metrics such as switching costs, economies of scale, current sales, brand loyalty, brand equity, capital investments, production rights, research & development activities, copyrights & patents, legislations, effects of promotional activities, and consumer preferences.
The information provided in our market research report is anticipated to help the industry stakeholders in the effective decision-making process and successful business outcomes. Moreover, we have been using Ansoff Matrix to help firms analyze and plan their business growth strategies.
Additionally, our report contains a growth-share matrix that aids firms’ business decisions for prioritizing their myriad businesses. We have also included GE Nine Cell Matrix that is helpful in making strategic planning and can help firms in determining their position in the market along with analyzing their growth strategies.
Our researchers also make use of the perceptual map to demonstrate how to target consumers feel about a given brand and form perception about it. We have also included the Customer-Based Brand Equity (CBBE) Model for helping firms effectively position their brands.
The key factors influencing the growth of the biologics outsourcing market have been assessed in the report. Factors having a huge influence on market demand and restraining factors that impact the development of the market are both addressed rigorously & in-depth in our global market research report.
Furthermore, trends that play a key role in market’s growth are discussed comprehensively in the report. Moreover, a large number of qualitative factors or measurements are included in the report and this includes operating risks and major obstacles encountered by players in the industry.
The report delivers a critical assessment on the biologics outsourcing market by segmenting it based on Products, Applications, and region. All the segments and categories of the biologics outsourcing market have been evaluated based on past, present and future trends and are key parameters determining & defining the growth of the market.
The data for the market and its segments and categories are provided from 2016 to 2028. The report has identified the key segments and categories contributing substantially towards overall market growth in terms of revenue & volume.
Based on Products, the global biologics outsourcing market is segmented into Antibody, Recombinant Protein, Vaccines, Others. Comprehensive qualitative and quantitative this segment analysis will be provided in the report from 2016 to 2028.
Based on Applications, market is divided into Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research. A slew of business growth opportunities and dynamics affecting the different segments are analyzed and discussed in the report.
The COVID-19 outbreak has wreaked havoc on worldwide economic and social systems. The disease has entered several industries' value and supply chains, including the biologics outsourcing market. The government imposed lockdowns in various locations. We will examine the impact of the COVID-19 pandemic on the global market, looking at both demand and supply.
The COVID-19 pandemic's short- and long-term impacts would be explored to provide a summary. This would help build business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users, during and after the epidemic.
On the basis of region, the market is segregated into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
The major players holding a huge chunk of market share in the global biologics outsourcing market and impacting market profitability are evaluated after considering their product & services revenue, sales, business plans, innovations, and growth rate. The final position of a player in the market depends on market events or market happenings, new product launches, mergers & acquisitions, benchmarking, regional expansions, and technical innovations.
For all the key stakeholders of the market, value chain and technology ecosystem, as well as the information provided in this market research report, will prove beneficial. The study offers an outline of the company’s market share and an extensive summary of the major players in the biologics outsourcing market.
Some of the leading players profiled in the global biologics outsourcing market are,
The report segments of the global biologics outsourcing market are as follows:
Primary sources include industry experts from management corporations, processing organizations, and analytical service providers who serve businesses across the sector's value chain. We interviewed key sources to acquire qualitative and quantitative data and analyse future prospects.
Primary research undertaken for this report comprised interviews with industry professionals such as CEOs, Vice Presidents, Marketing Directors and Technology Directors of strong core organizations and institutions in major biologics outsourcing . We interviewed them to get qualitative and quantitative data.
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Biologics Outsourcing Market Share by Type (2020-2026) 1.5.2 Antibody 1.5.3 Recombinant Protein 1.5.4 Vaccines 1.5.5 Others 1.6 Market by Application 1.6.1 Global Biologics Outsourcing Market Share by Application (2020-2026) 1.6.2 Vaccine & Therapeutics Development 1.6.3 Blood & Blood Related Products Testing 1.6.4 Cellular and Gene Therapy 1.6.5 Tissue and Tissue Related Products Testing 1.6.6 Stem Cell Research 1.7 Biologics Outsourcing Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Biologics Outsourcing Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Biologics Outsourcing Market 3.1 Value Chain Status 3.2 Biologics Outsourcing Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Biologics Outsourcing 3.2.3 Labor Cost of Biologics Outsourcing 3.2.3.1 Labor Cost of Biologics Outsourcing Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 GVK Biosciences Private Limited 4.1.1 GVK Biosciences Private Limited Basic Information 4.1.2 Biologics Outsourcing Product Profiles, Application and Specification 4.1.3 GVK Biosciences Private Limited Biologics Outsourcing Market Performance (2015-2020) 4.1.4 GVK Biosciences Private Limited Business Overview 4.2 Lonza 4.2.1 Lonza Basic Information 4.2.2 Biologics Outsourcing Product Profiles, Application and Specification 4.2.3 Lonza Biologics Outsourcing Market Performance (2015-2020) 4.2.4 Lonza Business Overview 4.3 Abzena PLC 4.3.1 Abzena PLC Basic Information 4.3.2 Biologics Outsourcing Product Profiles, Application and Specification 4.3.3 Abzena PLC Biologics Outsourcing Market Performance (2015-2020) 4.3.4 Abzena PLC Business Overview 4.4 Shanghai Medicilon inc. 4.4.1 Shanghai Medicilon inc. Basic Information 4.4.2 Biologics Outsourcing Product Profiles, Application and Specification 4.4.3 Shanghai Medicilon inc. Biologics Outsourcing Market Performance (2015-2020) 4.4.4 Shanghai Medicilon inc. Business Overview 4.5 GenScript 4.5.1 GenScript Basic Information 4.5.2 Biologics Outsourcing Product Profiles, Application and Specification 4.5.3 GenScript Biologics Outsourcing Market Performance (2015-2020) 4.5.4 GenScript Business Overview 4.6 Horizon Discovery Group plc 4.6.1 Horizon Discovery Group plc Basic Information 4.6.2 Biologics Outsourcing Product Profiles, Application and Specification 4.6.3 Horizon Discovery Group plc Biologics Outsourcing Market Performance (2015-2020) 4.6.4 Horizon Discovery Group plc Business Overview 4.7 Adimab LLC. 4.7.1 Adimab LLC. Basic Information 4.7.2 Biologics Outsourcing Product Profiles, Application and Specification 4.7.3 Adimab LLC. Biologics Outsourcing Market Performance (2015-2020) 4.7.4 Adimab LLC. Business Overview 4.8 Boehringer Ingelheim GmbH 4.8.1 Boehringer Ingelheim GmbH Basic Information 4.8.2 Biologics Outsourcing Product Profiles, Application and Specification 4.8.3 Boehringer Ingelheim GmbH Biologics Outsourcing Market Performance (2015-2020) 4.8.4 Boehringer Ingelheim GmbH Business Overview 4.9 Catalent, Inc. 4.9.1 Catalent, Inc. Basic Information 4.9.2 Biologics Outsourcing Product Profiles, Application and Specification 4.9.3 Catalent, Inc. Biologics Outsourcing Market Performance (2015-2020) 4.9.4 Catalent, Inc. Business Overview 4.10 Innovent Biologics, Inc. 4.10.1 Innovent Biologics, Inc. Basic Information 4.10.2 Biologics Outsourcing Product Profiles, Application and Specification 4.10.3 Innovent Biologics, Inc. Biologics Outsourcing Market Performance (2015-2020) 4.10.4 Innovent Biologics, Inc. Business Overview 4.11 Selexis SA 4.11.1 Selexis SA Basic Information 4.11.2 Biologics Outsourcing Product Profiles, Application and Specification 4.11.3 Selexis SA Biologics Outsourcing Market Performance (2015-2020) 4.11.4 Selexis SA Business Overview 4.12 Syngene 4.12.1 Syngene Basic Information 4.12.2 Biologics Outsourcing Product Profiles, Application and Specification 4.12.3 Syngene Biologics Outsourcing Market Performance (2015-2020) 4.12.4 Syngene Business Overview 4.13 Innovent Biologics, Inc. 4.13.1 Innovent Biologics, Inc. Basic Information 4.13.2 Biologics Outsourcing Product Profiles, Application and Specification 4.13.3 Innovent Biologics, Inc. Biologics Outsourcing Market Performance (2015-2020) 4.13.4 Innovent Biologics, Inc. Business Overview 4.14 GL Biochem Corporation Ltd. 4.14.1 GL Biochem Corporation Ltd. Basic Information 4.14.2 Biologics Outsourcing Product Profiles, Application and Specification 4.14.3 GL Biochem Corporation Ltd. Biologics Outsourcing Market Performance (2015-2020) 4.14.4 GL Biochem Corporation Ltd. Business Overview 5 Global Biologics Outsourcing Market Analysis by Regions 5.1 Global Biologics Outsourcing Sales, Revenue and Market Share by Regions 5.1.1 Global Biologics Outsourcing Sales by Regions (2015-2020) 5.1.2 Global Biologics Outsourcing Revenue by Regions (2015-2020) 5.2 North America Biologics Outsourcing Sales and Growth Rate (2015-2020) 5.3 Europe Biologics Outsourcing Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Biologics Outsourcing Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Biologics Outsourcing Sales and Growth Rate (2015-2020) 5.6 South America Biologics Outsourcing Sales and Growth Rate (2015-2020) 6 North America Biologics Outsourcing Market Analysis by Countries 6.1 North America Biologics Outsourcing Sales, Revenue and Market Share by Countries 6.1.1 North America Biologics Outsourcing Sales by Countries (2015-2020) 6.1.2 North America Biologics Outsourcing Revenue by Countries (2015-2020) 6.1.3 North America Biologics Outsourcing Market Under COVID-19 6.2 United States Biologics Outsourcing Sales and Growth Rate (2015-2020) 6.2.1 United States Biologics Outsourcing Market Under COVID-19 6.3 Canada Biologics Outsourcing Sales and Growth Rate (2015-2020) 6.4 Mexico Biologics Outsourcing Sales and Growth Rate (2015-2020) 7 Europe Biologics Outsourcing Market Analysis by Countries 7.1 Europe Biologics Outsourcing Sales, Revenue and Market Share by Countries 7.1.1 Europe Biologics Outsourcing Sales by Countries (2015-2020) 7.1.2 Europe Biologics Outsourcing Revenue by Countries (2015-2020) 7.1.3 Europe Biologics Outsourcing Market Under COVID-19 7.2 Germany Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.2.1 Germany Biologics Outsourcing Market Under COVID-19 7.3 UK Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.3.1 UK Biologics Outsourcing Market Under COVID-19 7.4 France Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.4.1 France Biologics Outsourcing Market Under COVID-19 7.5 Italy Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.5.1 Italy Biologics Outsourcing Market Under COVID-19 7.6 Spain Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.6.1 Spain Biologics Outsourcing Market Under COVID-19 7.7 Russia Biologics Outsourcing Sales and Growth Rate (2015-2020) 7.7.1 Russia Biologics Outsourcing Market Under COVID-19 8 Asia-Pacific Biologics Outsourcing Market Analysis by Countries 8.1 Asia-Pacific Biologics Outsourcing Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Biologics Outsourcing Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Biologics Outsourcing Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Biologics Outsourcing Market Under COVID-19 8.2 China Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.2.1 China Biologics Outsourcing Market Under COVID-19 8.3 Japan Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.3.1 Japan Biologics Outsourcing Market Under COVID-19 8.4 South Korea Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.4.1 South Korea Biologics Outsourcing Market Under COVID-19 8.5 Australia Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.6 India Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.6.1 India Biologics Outsourcing Market Under COVID-19 8.7 Southeast Asia Biologics Outsourcing Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Biologics Outsourcing Market Under COVID-19 9 Middle East and Africa Biologics Outsourcing Market Analysis by Countries 9.1 Middle East and Africa Biologics Outsourcing Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Biologics Outsourcing Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Biologics Outsourcing Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Biologics Outsourcing Market Under COVID-19 9.2 Saudi Arabia Biologics Outsourcing Sales and Growth Rate (2015-2020) 9.3 UAE Biologics Outsourcing Sales and Growth Rate (2015-2020) 9.4 Egypt Biologics Outsourcing Sales and Growth Rate (2015-2020) 9.5 Nigeria Biologics Outsourcing Sales and Growth Rate (2015-2020) 9.6 South Africa Biologics Outsourcing Sales and Growth Rate (2015-2020) 10 South America Biologics Outsourcing Market Analysis by Countries 10.1 South America Biologics Outsourcing Sales, Revenue and Market Share by Countries 10.1.1 South America Biologics Outsourcing Sales by Countries (2015-2020) 10.1.2 South America Biologics Outsourcing Revenue by Countries (2015-2020) 10.1.3 South America Biologics Outsourcing Market Under COVID-19 10.2 Brazil Biologics Outsourcing Sales and Growth Rate (2015-2020) 10.2.1 Brazil Biologics Outsourcing Market Under COVID-19 10.3 Argentina Biologics Outsourcing Sales and Growth Rate (2015-2020) 10.4 Columbia Biologics Outsourcing Sales and Growth Rate (2015-2020) 10.5 Chile Biologics Outsourcing Sales and Growth Rate (2015-2020) 11 Global Biologics Outsourcing Market Segment by Types 11.1 Global Biologics Outsourcing Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Biologics Outsourcing Sales and Market Share by Types (2015-2020) 11.1.2 Global Biologics Outsourcing Revenue and Market Share by Types (2015-2020) 11.2 Antibody Sales and Price (2015-2020) 11.3 Recombinant Protein Sales and Price (2015-2020) 11.4 Vaccines Sales and Price (2015-2020) 11.5 Others Sales and Price (2015-2020) 12 Global Biologics Outsourcing Market Segment by Applications 12.1 Global Biologics Outsourcing Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Biologics Outsourcing Sales and Market Share by Applications (2015-2020) 12.1.2 Global Biologics Outsourcing Revenue and Market Share by Applications (2015-2020) 12.2 Vaccine & Therapeutics Development Sales, Revenue and Growth Rate (2015-2020) 12.3 Blood & Blood Related Products Testing Sales, Revenue and Growth Rate (2015-2020) 12.4 Cellular and Gene Therapy Sales, Revenue and Growth Rate (2015-2020) 12.5 Tissue and Tissue Related Products Testing Sales, Revenue and Growth Rate (2015-2020) 12.6 Stem Cell Research Sales, Revenue and Growth Rate (2015-2020) 13 Biologics Outsourcing Market Forecast by Regions (2020-2026) 13.1 Global Biologics Outsourcing Sales, Revenue and Growth Rate (2020-2026) 13.2 Biologics Outsourcing Market Forecast by Regions (2020-2026) 13.2.1 North America Biologics Outsourcing Market Forecast (2020-2026) 13.2.2 Europe Biologics Outsourcing Market Forecast (2020-2026) 13.2.3 Asia-Pacific Biologics Outsourcing Market Forecast (2020-2026) 13.2.4 Middle East and Africa Biologics Outsourcing Market Forecast (2020-2026) 13.2.5 South America Biologics Outsourcing Market Forecast (2020-2026) 13.3 Biologics Outsourcing Market Forecast by Types (2020-2026) 13.4 Biologics Outsourcing Market Forecast by Applications (2020-2026) 13.5 Biologics Outsourcing Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Biologics Outsourcing
Biologics Outsourcing
×